Otsuka America Pharmaceutical, Inc.

OAPI oversees commercial activities in the U.S. with a focus on developing products in neuroscience, oncology, and cardio-renal. It is our goal to deliver the most efficient, effective medicines, and the best value to our customers.

CEO

Kabir Nath

PRESIDENT & CEO

Kabir assumed the role of President & CEO of Otsuka North America Pharmaceuticals in March 2016. Prior to this position, Kabir worked as the Senior Vice President of Virology US Pharmaceuticals for Bristol-Myers Squibb.

View Bio

EXPLORE

WEBSITE CAREERS NEWS

CONTACT

2440 Research Blvd,
Rockville, MD 20850,
United States

Tel: 1-301-424-9055